Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of Erie Retina Research—one of the nation’s premier retina research centers led by Dr. David Almeida, MD, MBA, PhD—which will operate as a wholly owned subsidiary of Lexitas. As part of the transaction, Lexitas also acquired CASExERIE, LLC, an ophthalmic innovation hub specializing in advanced research, surgical training, and retina-focused product development. CASExERIE will continue to operate within Erie Retina Research. Lexitas is also acquiring the assets of Element Erie: Imaging & Reading Center PLLC, a dedicated center focused on the expert review and interpretation of ophthalmic imaging used in clinical trials.
Read the full article: Lexitas Pharma Services, a Leading Ophthalmology CRO, Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie //
Source: https://www.businesswire.com/news/home/20260519910995/en/Lexitas-Pharma-Services-a-Leading-Ophthalmology-CRO-Announces-the-Acquisition-of-Erie-Retina-Research-CASExERIE-and-Element-Erie